Video released this week shows Ukraine launching domestically produced FP-5 "Flamingo" cruise missiles, as Kyiv pushes deeper strikes on Russian military infrastructure nearly four years into the war.

Ukraine’s military said the missiles were used in an overnight attack on February 11 to 12 targeting a missile, ammunition and an explosives arsenal near the settlement of Kotluban in Russia’s Volgograd Oblast, describing the facility as belonging to Russia’s Main Missile and Artillery Directorate, known as GRAU, and said it was among the largest ammunition storage hubs used by Russian forces. 

Ukrainian officials said powerful explosions and secondary detonations were recorded at the site, while the extent of damage was still being assessed.

RUSSIAN ATTACK ON KHARKIV WIPES OUT YOUNG FAMILY, LEAVING PREGNANT MOTHER AS SOLE SURVIVOR

Russian regional authorities acknowledged an incident at a Defense Ministry facility in the same area. Volgograd Governor Andrey Bocharov said air defenses repelled a missile attack and that falling debris triggered a fire at a military facility near Kotluban. He said an evacuation of nearby residents was ordered during firefighting because of the threat of detonation. Anadolu Agency reported that buses were prepared to move residents to temporary accommodation centers.

Russia’s Defense Ministry has also publicly referenced the Flamingo system. In a daily update carried by Russian state media, the ministry said its air defenses shot down five Flamingo long-range cruise missiles over the previous 24 hours. The ministry did not provide evidence in the statement, and Kyiv has not confirmed how many missiles were intercepted.

BATTERED IN UKRAINE, RUSSIA RACES TO REARM — BUT QUESTIONS LINGER OVER ITS MILITARY STRENGTH

Ukraine has increasingly highlighted indigenous long-range capabilities, including the FP-5. An East-to-West News agency video report previously cited Ukrainian officials describing the missile’s range as 3,000 kilometers, or about 1,864 miles, and said officials claim accuracy within about 14 meters, though battlefield performance is difficult to independently verify.

In response to a reporter's question on the talks between the sides, President Donald Trump put the onus back on President Zelenskyy to make a deal. 

"Well, Zelenskyy is going to have to get moving. Russia wants to make a deal, and Zelenskyy is going to have to get moving otherwise, he's going to miss a great opportunity. He has to move," he said.

 A new round of U.S.-brokered talks between Russia and Ukraine is expected in Geneva next week, even as fighting persists along the more than 1,200-kilometer front line.

Ukrainian officials said Russian attacks across Ukraine continue, saying on Friday that a Russian drone assault on port infrastructure near Odesa killed one person and injured six others, while a separate strike near the eastern front line killed three brothers, including an eight-year-old and wounded their mother and grandmother.

FIRST ON FOX: A Senate Republican is demanding the Food and Drug Administration (FDA) investigate whether illegal Chinese ingredients are making their way into weight loss drugs in the United States.

Sen. Tom Cotton, R-Ark., called on FDA Commissioner Martin Makary to probe how far unregulated and illegal Chinese active pharmaceutical ingredients have penetrated the U.S. supply chain — and whether they have ended up in popular weight loss drugs.

"China’s access to America’s pharmaceutical supply chain presents national security risks as well as significant health risks to American patients," Cotton wrote in a letter to Makary first obtained by Fox News Digital.

JELLY ROLL'S WIFE SAYS WEIGHT LOSS DRUG SENT HER INTO ‘WORST SUICIDAL DEPRESSION’

Cotton’s concern follows recent reports from the FDA and Customs and Border Protection (CBP) that between September 2023 and January 2025, authorities intercepted 195 illegal shipments of active pharmaceutical ingredients.

He noted that the ingredients were "likely used in compounded weight loss medications" that entered the U.S. market. Of those shipments, roughly 60 originated from China and Hong Kong.

"It is estimated that as of January 2026, up to 1.5 million American patients could be using unregulated compounded weight loss medications that may contain potentially dangerous ingredients from Chinese manufacturers," Cotton wrote.

EXAMINING THE NEXT THREAT FROM COMMUNIST CHINA: OUR HEALTHCARE SYSTEM

The ingredients are typically used in compounded versions of GLP-1 weight loss drugs that are marketed as alternatives to FDA-approved medications such as Ozempic and Wegovy.

Earlier this month, the Department of Health and Human Services announced it would refer telehealth company Hims & Hers to the Justice Department for "potential violations of the Federal Food, Drug, and Cosmetic Act" over its planned sale of a compounded, non-FDA-approved weight loss drug.

Makary similarly said the FDA would "take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies — including Hims & Hers and other compounding pharmacies — as alternatives to FDA-approved drugs."

FETTERMAN BUCKS DEMOCRATS, SAYS PARTY PUT POLITICS OVER COUNTRY IN DHS SHUTDOWN STANDOFF

The company announced last week that it would remove its weight loss pill, billed as a cheaper alternative to Wegovy, from the market following mounting pressure from federal agencies.

Cotton acknowledged that move and called for similar investigations going forward.

"I encourage further investigations into other entities that expose American patients to dangerous, unregulated Chinese APIs," Cotton wrote.